COG 133 TFA is a fragment of Apolipoprotein E (APOE) peptide. COG 133 TFA competes with the ApoE holoprotein for binding the LDL receptor, with potent anti-inflammatory and neuroprotective effects. COG 133 TFA is also a nAChR antagonist with an IC50 of 445 nM.
体内研究
COG 133 (1 mg/kg; intratracheal administration; Every other day; Continuous treatment for 4 weeks can impair the resolution of pulmonary fibrosis in mice.
Animal Model:
Male C57BL/6 mice (6-week-old) instilled with Bleomycin
Dosage:
1 mg/kg
Administration:
Intratracheal administration; every other day; for 4 weeks
Result:
Did blunt the resolution of lung fibrosis.
分子式
C99H182F3N37O21
分子量
2283.78
CAS号
2828432-37-5
中文名称
COG 133 TFA
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder
-20°C
3 years
4°C
2 years
In solvent
-80°C
6 months
-20°C
1 month
溶解性数据
In Vitro:
H2O : 25 mg/mL (Need ultrasonic)
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: